Good CC ....The CC led me to think....
-a nice pick up in growth coming -especially US..
-the latest US aquisition could do $5 to $6 mill sales in 2016
-the latest US aquisition was not promoted to doctors
-since the latest aquisition has both a brand and authorized generic, new US products they go after could be either also...this make the sphere of potential products very large
-being in both Canada and US will help them land good products since some products are only available in one or the other, and in some cases only available for both combined..
-the lower tax base in Barbados will help International expansion...
-TRX will be innovative with tech in marketing to doctors in the US..
-only going after mature products for US (smart since they do not need as much educational selling)
-they could not specify any future deals coming but from all the parties who spoke the non direct message was that deals are very high priority..
-IMO the US strategy is great, as I expected, and glad to be a shareholder here..
GLTA...